The basis of liver regeneration: A systems biology approach.


Journal

Annals of hepatology
ISSN: 1665-2681
Titre abrégé: Ann Hepatol
Pays: Mexico
ID NLM: 101155885

Informations de publication

Date de publication:
Historique:
received: 19 01 2018
revised: 18 06 2018
accepted: 01 07 2018
pubmed: 3 5 2019
medline: 7 8 2020
entrez: 4 5 2019
Statut: ppublish

Résumé

Liver regeneration is a normal response to liver injury. The aim of this study was to determine the molecular basis of liver regeneration, through an integrative analysis of high-throughput gene expression datasets. We identified and curated datasets pertaining to liver regeneration from the Gene Expression Omnibus, where regenerating liver tissue was compared to healthy liver samples. The key dysregulated genes and pathways were identified using Ingenuity Pathway Analysis software. There were three eligible datasets in total. In the early phase after hepatectomy, inflammatory pathways such as Nrf2 oxidative stress-mediated response and cytokine signaling were significantly upregulated. At peak regeneration, we discovered that cell cycle genes were predominantly expressed to promote cell proliferation. Using the Betweenness centrality algorithm, we discovered that Jun is the key central gene in liver regeneration. Calcineurin inhibitors may inhibit liver regeneration, based on predictive modeling. There is a paucity of human literature in defining the molecular mechanisms of liver regeneration along a time continuum. Nonetheless, using an integrative computational analysis approach to the available high-throughput data, we determine that the oxidative stress response and cytokine signaling are key early after hepatectomy, whereas cell cycle control is important at peak regeneration. The transcription factor Jun is central to liver regeneration and a potential therapeutic target. Future studies of regeneration in humans along a time continuum are needed to better define the underlying mechanisms, and ultimately enhance care of patients with acute and chronic liver failure while awaiting transplant.

Identifiants

pubmed: 31047847
pii: S1665-2681(19)30046-8
doi: 10.1016/j.aohep.2018.07.003
pii:
doi:

Substances chimiques

Tumor Necrosis Factor-alpha 0
Fibroblast Growth Factors 62031-54-3
Epidermal Growth Factor 62229-50-9

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

422-428

Informations de copyright

Copyright © 2019 Fundación Clínica Médica Sur, A.C. Published by Elsevier España, S.L.U. All rights reserved.

Auteurs

Mamatha Bhat (M)

Multi Organ Transplant Program, University Health Network, Toronto, Canada; Division of Gastroenterology and Hepatology, University Health Network and University of Toronto, Toronto, Canada. Electronic address: Mamatha.bhat@uhn.ca.

Elisa Pasini (E)

Multi Organ Transplant Program, University Health Network, Toronto, Canada.

Cristina Baciu (C)

Multi Organ Transplant Program, University Health Network, Toronto, Canada.

Marc Angeli (M)

Multi Organ Transplant Program, University Health Network, Toronto, Canada.

Atul Humar (A)

Multi Organ Transplant Program, University Health Network, Toronto, Canada.

Sonya Macparland (S)

Multi Organ Transplant Program, University Health Network, Toronto, Canada; Department of Laboratory Medicine and Pathobiology, Toronto, Canada.

Jordan Feld (J)

Division of Gastroenterology and Hepatology, University Health Network and University of Toronto, Toronto, Canada; Toronto Centre for Liver Disease, University of Toronto, Ontario, Canada.

Ian McGilvray (I)

Multi Organ Transplant Program, University Health Network, Toronto, Canada; Department of Laboratory Medicine and Pathobiology, Toronto, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH